Ann: NTCELL Parkinsons trial patient data 2 years after implant, page-52

I don't understand illdrink2that that the company comes with such a statement which only gives us a lot of uncertainty , you can see that in the share price down 50 % ,I only hope thinks will turn around for us with a new member to the board of directors and the same person as a member to the medical advisory board , a young highly qualified person with up to date ideas. Plus a new member coming soon to join the board of directors with COMERCIAL experience .
The next two weeks will tell , keep mij fingers X, I can do without the stress !!!